US 11512060
1,2,4-oxadiazole derivatives as immunomodulators
granted A61KA61K31/395A61K31/4245
Quick answer
US patent 11512060 (1,2,4-oxadiazole derivatives as immunomodulators) held by Aurigene Discovery Technologies Limited expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aurigene Discovery Technologies Limited
- Grant date
- Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/395, A61K31/4245, A61K31/433, A61K45/06